Skyrocketing insulin prices put millions at risk of rationing the lifesaving drug. But policy fixes like capping costs seek to ease the affordability crisis.
Skyrocketing insulin prices put millions at risk of rationing the lifesaving drug. But policy fixes like capping costs seek to ease the affordability crisis.